Disclosed are compounds of the formula I
1
and pharmaceutically acceptable salts and prodrugs thereof,
wherein W, t, R
1
, R
2
, R
7
, R
9
, R
10
, R
11
and R
12
are as defined in the specification.
Such compounds are MEK inhibitors and useful in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals. Also disclosed is a method of using such compounds in the treatment of hyperproliferative diseases in mammals, and pharmaceutical compositions containing such compounds.
揭示了公式I1的化合物及其药用盐和前药,其中W、t、R1、R2、R7、R9、R10、R11和R12如规范中所定义。这些化合物是MEK
抑制剂,在哺乳动物中对治疗高增殖性疾病,如癌症和炎症,具有用处。还揭示了在哺乳动物中使用这些化合物治疗高增殖性疾病的方法,以及含有这些化合物的药物组合物。